Everolimus 70377-0010-22
- Manufacturer
- Biocon Pharma Inc.
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- October 1, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA214182
Need to source Everolimus? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Everolimus | 2.5 mg/1 |
Drug Class
Kinase Inhibitor [EPC]mTOR Inhibitor Immunosuppressant [EPC]Cytochrome P450 2D6 Inhibitors [MoA]
Selected Package
70377-0010-22Selected4 BLISTER PACK in 1 CARTON (70377-010-22) / 7 TABLET in 1 BLISTER PACK
Other packages for this product(2)
30 TABLET in 1 BOTTLE (70377-010-11)
4 BLISTER PACK in 1 CARTON (70377-010-23) / 7 TABLET in 1 BLISTER PACK